Doctors Slam Cholesterol Drugs Over Safety Concerns

Law360, New York (March 31, 2008, 12:00 AM EDT) -- In a blow to Merck & Co. Inc. and Schering-Plough Corp., a panel of four cardiologists has reportedly recommended against using two of the companies' jointly marketed cholesterol-lowering drugs, saying the drugs may not work and should be used only as a last resort.

The doctors made the recommendation at a cardiology conference on Sunday during which researchers presented full results of the "Enhance" study, which showed that the drugs, Vytorin and Zetia, worked no better than Zocor – an older, cheaper drug – to prevent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.